The Valley Desk

ArticleRedox biologyPublished

Small molecule screen identifies pyrimethamine as an inhibitor of NRF2-driven esophageal hyperplasia

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Cooper Norcross Health, Cooper Medical School of Rowan University, Coriell Institute for Medical Research, with Rowan University linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Redox biology
Published
Subject terms
Cell Line, Tumor; Animals; Humans; Mice; Esophageal Neoplasms; Hyperplasia; Pyrimethamine; Cell Proliferation; NF-E2-Related Factor 2; Esophageal Squamous Cell Carcinoma; Mitoxantrone; esophageal squamous cell carcinoma
PubMed ID
37776708
PubMed Central ID
PMC10558795
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal